MBOT
Income statement / Annual
Last year (2023), Microbot Medical Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Microbot Medical Inc.'s net income was -$10.74 M.
See Microbot Medical Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$117,000.00
|
$1.01 M
|
Cost of Revenue |
$106,000.00 |
$102,000.00 |
$76,000.00 |
$68,000.00 |
$84,000.00 |
$54,000.00 |
$21,000.00 |
$10,000.00 |
$17,000.00 |
$0.00 |
Gross Profit |
-$106,000.00 |
-$102,000.00 |
-$76,000.00 |
-$68,000.00 |
-$84,000.00 |
-$54,000.00 |
-$21,000.00 |
-$10,000.00 |
$100,000.00 |
$1.01 M |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0.85 |
1 |
Research and Development
Expenses |
$5.72 M
|
$7.74 M
|
$6.15 M
|
$3.40 M
|
$3.05 M
|
$2.52 M
|
$1.10 M
|
$901,000.00
|
$27.11 M
|
$21.50 M
|
General & Administrative
Expenses |
$4.13 M
|
$5.43 M
|
$5.09 M
|
$5.56 M
|
$4.03 M
|
$4.50 M
|
$4.01 M
|
$8.73 M
|
$9.33 B
|
$65.11
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$23,000.00
|
$26,000.00
|
$180,000.00
|
-$9.32 B
|
$10.42 M
|
Selling, General &
Administrative Expenses |
$4.13 M
|
$5.43 M
|
$5.09 M
|
$5.56 M
|
$4.03 M
|
$4.52 M
|
$4.04 M
|
$8.73 M
|
$9.33 M
|
$10.42 M
|
Other Expenses |
$0.00 |
$120,000.00 |
$112,000.00 |
$130,000.00 |
$165,000.00 |
$205,000.00 |
$130,000.00 |
-$180,000.00 |
$130,000.00 |
-$46,000.00 |
Operating Expenses |
$9.86 M |
$13.28 M |
$11.36 M |
$9.09 M |
$7.24 M |
$7.24 M |
$5.27 M |
$9.64 M |
$36.45 M |
$31.92 M |
Cost And Expenses |
$9.86 M |
$13.28 M |
$11.36 M |
$9.09 M |
$7.24 M |
$7.24 M |
$5.27 M |
$9.64 M |
$36.45 M |
$31.92 M |
Interest Income |
$0.00 |
$54,000.00 |
$44.00 |
$80.00 |
$103.00 |
$0.00 |
$0.00 |
$0.00 |
$7,544.00 |
$8,532.00 |
Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$80,000.00 |
$103,000.00 |
$0.00 |
$238,000.00 |
$334,000.00 |
$506,319.00 |
$1.30 M |
Depreciation &
Amortization |
-$779,000.00
|
$102,000.00
|
$76,000.00
|
$68,000.00
|
$84,000.00
|
$54,000.00
|
$21,000.00
|
$10,000.00
|
$1.13 M
|
$1.31 M
|
EBITDA |
-$10.63 M
|
-$13.18 M
|
-$11.28 M
|
-$9.02 M
|
-$7.16 M
|
-$7.19 M
|
-$5.25 M
|
-$9.63 M
|
-$897,000.00
|
-$29.66 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-312.91 |
-30.53 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-313.85
|
-30.54
|
Total Other
Income/Expenses Net |
-$885,000.00
|
$113,000.00
|
$44,000.00
|
-$80,000.00
|
-$7,000.00
|
$4,000.00
|
-$2.32 M
|
-$28,000.00
|
-$6,000.00
|
-$31.36 M
|
Income Before Tax |
-$10.74 M |
-$13.17 M |
-$11.31 M |
-$9.17 M |
-$7.25 M |
-$7.24 M |
-$7.59 M |
-$9.66 M |
-$36.41 M |
-$32.26 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-311.23
|
-31.88
|
Income Tax Expense |
$0.00 |
-$118.00 M |
-$44,000.00 |
$80,000.00 |
$103,000.00 |
-$14.48 M |
$2.32 M |
$28,000.00 |
-$908,696.00 |
$477,797.00 |
Net Income |
-$10.74 M |
$104.83 M |
-$11.27 M |
-$9.25 M |
-$7.35 M |
-$7.24 M |
-$7.59 M |
-$9.66 M |
-$36.42 M |
-$32.74 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-311.24 |
-32.35 |
EPS |
-1.05 |
14.44 |
-1.59 |
-1.3 |
-1.72 |
-2.49 |
-3.48 |
-10.14 |
-497.22 |
-860.88 |
EPS Diluted |
-1.05 |
14.44 |
-1.59 |
-1.3 |
-1.72 |
-2.49 |
-3.48 |
-10.14 |
-497.22 |
-860.88 |
Weighted Average Shares
Out |
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$2.90 M
|
$2.18 M
|
$952,886.00
|
$73,237.00
|
$38,032.00
|
Weighted Average Shares
Out Diluted |
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$2.90 M
|
$2.18 M
|
$952,920.00
|
$73,237.00
|
$38,032.00
|
Link |
|
|
|
|
|
|
|
|
|
|